HeartSciences Inc.
NASDAQ Capital MarketTotal Valuation
HeartSciences Inc. carries a market capitalization of 172,631.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 172,631.00 |
| Enterprise Value | 2.51M |
Share Statistics
HeartSciences Inc. currently has 3.18M shares outstanding.
| Shares Outstanding | 3.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 1.00 |
| P/TBV Ratio | -0.10 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 580.13 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
HeartSciences Inc. maintains a current ratio of 0.53, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,741.42, indicating moderate leverage, while an interest coverage ratio of -11.00 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.53 |
| Quick Ratio | 0.34 |
| Debt / Equity | 1,741.42 |
| Debt / EBITDA | -0.48 |
| Interest Coverage | -11.00 |
Financial Efficiency
| Return on Equity (ROE) | -4,252.65 |
| Return on Assets (ROA) | -192.75 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.00 |
Stock Price Statistics
HeartSciences Inc.'s stock has gained approximately 8.48586% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 8.48586% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -8.28M, while operating income came in at -8.41M.
| Revenue | 4,319.00 |
| Gross Profit | 2,551.00 |
| Operating Income | -8.41M |
| Pretax Income | -9.14M |
| Net Income | -9.14M |
| EBITDA | -8.28M |
| EBIT | -8.41M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
HeartSciences Inc. holds 1.66M in cash and equivalents against 3.94M in total debt, resulting in a net debt position of 1.97M. Total book value stands at 225,147.00, with working capital of -2.28M providing operational flexibility.
| Cash & Cash Equivalents | 1.66M |
| Total Debt | 3.94M |
| Net Debt | 1.97M |
| Equity (Book Value) | 225,147.00 |
| Book Value Per Share | 0.07 |
| Working Capital | -2.28M |
Cash Flow
HeartSciences Inc. produced -7.43M in operating cash flow over the past twelve months.
| Operating Cash Flow | -7.43M |
| Capital Expenditures | -31,422.00 |
| Free Cash Flow | -7.46M |
| FCF Per Share | N/A |
Margins
HeartSciences Inc. operates with a gross margin of 59.06, reflecting its pricing power and cost economics. The operating margin of -194,787.38 and net profit margin of -211,666.47 provide insight into operational efficiency.
| Gross Margin | 59.06 |
| Operating Margin | -194,787.38 |
| Pretax Margin | -211,666.47 |
| Profit Margin | -211,666.47 |
| EBITDA Margin | -191,746.17 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3,571.38 |
| FCF Yield | N/A |
Scores
HeartSciences Inc. posts an Altman Z-Score of -51.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -51.83 |